Matthew Matava, MD
Orthopaedic Surgery · Chesterfield, MONPI 1588680706
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $94,806 of the $134,684 with a category attached, or 70.4%. Arthrex accounts for 95.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $38,476 and has fallen 57.6% since, to $16,327 in 2025. Among orthopaedic surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $565.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$128K
- Elite Orthopedics, LLC$4K
- Heron Therapeutics, Inc.$2K
- BREG, Inc$337
- Stryker$142
What the payments were for
- Consulting fees$22,08016%
- Speaking & faculty fees$94,80670%
- Travel & lodging$10,9948%
- Food & beverage$4,0003%
- Education$2,8032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 206 | $128,015 |
| Elite Orthopedics, LLC | 26 | $4,069 |
| Heron Therapeutics, Inc. | 2 | $2,122 |
| BREG, Inc | 3 | $337 |
| Stryker | 1 | $142 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$134,684 in reported general payments places this provider in the 95th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $251 |
| Meloxicam | 75 | $97 |
| Ondansetron Hcl | 31 | $95 |
| Tramadol Hcl | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chesterfield
- Emily WhickerChesterfield$39K
- Matthew SmithColumbia$2.9M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Peter ChalmersSaint Louis$603K
- Katherine BurnsBridgeton$491K
- Jeremy StattonLees Summit$457K
- Lionel MetzSaint Louis$428K
- Michael HellmanLees Summit$365K
- Jon CarlsonSaint Louis$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.